NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets - Pfaff, Elke; Adam de Beaumais, Tiphaine; Marchais, Antonin; Tilburg, Cornelis M. van; Blattner-Johnson, Mirjam; Dirksen, Uta; Øra, Ingrid; Geoerger, Birgit; Schleiermacher, Gudrun; Pfister, Stefan; Witt, Olaf; Jones, David T. W.; et al. (JCO precision oncology, 2021)
Gesehen am 27.05.2021